IRADIMED CORPORATION Increase (Decrease) in Other Current Liabilities
IRADIMED CORPORATION (IRMD) reported Increase (Decrease) in Other Current Liabilities of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-31.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherCurrentLiabilities · last filed 2026-07-31
- IRADIMED CORPORATION increase (decrease) in other current liabilities for the quarter ending 2026-06-30 was $0.00.
- IRADIMED CORPORATION increase (decrease) in other current liabilities for the quarter ending 2026-03-31 was $0.00.
- IRADIMED CORPORATION increase (decrease) in other current liabilities for the quarter ending 2025-12-31 was $0.00.
- IRADIMED CORPORATION increase (decrease) in other current liabilities for the quarter ending 2025-09-30 was $0.00.
- IRADIMED CORPORATION increase (decrease) in other current liabilities for fiscal 2025 was -$150.00K.
- IRADIMED CORPORATION increase (decrease) in other current liabilities for fiscal 2024 was -$100.00K, a 140.00% decline from fiscal 2023.
- IRADIMED CORPORATION increase (decrease) in other current liabilities for fiscal 2023 was $250.00K.
- IRADIMED CORPORATION increase (decrease) in other current liabilities for fiscal 2022 was -$146.44K.
| Period end | Increase (Decrease) in Other Current Liabilities 3 month | Increase (Decrease) in Other Current Liabilities 6 month | Increase (Decrease) in Other Current Liabilities 9 month | Increase (Decrease) in Other Current Liabilities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-31 | $0.00 10-Q · filed 2026-07-31 | $0.00 derived: sum of 3 quarters · filed 2026-07-31 | $0.00 derived: sum of 4 quarters · filed 2026-07-31 |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-01 | $0.00 derived: sum of 2 quarters · filed 2026-05-01 | $0.00 derived: sum of 3 quarters · filed 2026-05-01 | $0.00 derived: sum of 4 quarters · filed 2026-07-31 |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-06 | $0.00 derived: sum of 2 quarters · filed 2026-03-06 | $0.00 derived: sum of 3 quarters · filed 2026-07-31 | -$150.00K 10-K · filed 2026-03-06 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | $0.00 derived: sum of 2 quarters · filed 2026-07-31 | -$150.00K 10-Q · filed 2025-11-03 | |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-31 | -$150.00K 10-Q · filed 2026-07-31 | ||
| 2025-03-31 | -$150.00K 10-Q · filed 2026-05-01 | |||
| 2024-12-31 | -$100.00K 10-K · filed 2026-03-06 | |||
| 2023-12-31 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2025-09-03 | $0.00 derived: sum of 2 quarters · filed 2025-09-03 | $0.00 derived: sum of 3 quarters · filed 2025-09-03 | $250.00K 10-K/A · filed 2025-09-03 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | $0.00 derived: sum of 2 quarters · filed 2024-10-31 | $250.00K 10-Q · filed 2024-10-31 | $113.07K derived: sum of 4 quarters · filed 2024-10-31 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $250.00K 10-Q · filed 2024-08-01 | $113.07K derived: sum of 3 quarters · filed 2024-08-01 | $111.56K derived: sum of 4 quarters · filed 2024-08-01 |
| 2023-03-31 | $250.00K 10-Q · filed 2024-05-02 | $113.07K derived: sum of 2 quarters · filed 2024-05-02 | $111.56K derived: sum of 3 quarters · filed 2024-05-02 | $111.56K derived: sum of 4 quarters · filed 2024-05-02 |
| 2022-12-31 | -$136.93K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-01 | -$138.44K derived: sum of 2 quarters · filed 2024-03-01 | -$138.44K derived: sum of 3 quarters · filed 2024-03-01 | -$146.44K 10-K · filed 2024-03-01 |
| 2022-09-30 | -$1.51K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | -$1.51K derived: sum of 2 quarters · filed 2023-11-03 | -$9.51K 10-Q · filed 2023-11-03 | |
| 2022-06-30 | -$1.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | -$8.00K 10-Q · filed 2023-08-03 | ||
| 2022-03-31 | -$7.99K 10-Q · filed 2023-05-04 | |||
| 2020-12-31 | $2.37M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-04 | $6.87K derived: sum of 2 quarters · filed 2022-03-04 | $38.01K 10-K · filed 2022-03-04 | |
| 2020-09-30 | -$2.37M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05 | -$2.34M 10-Q · filed 2021-11-05 | ||
| 2020-06-30 | $31.14K 10-Q · filed 2021-08-06 | |||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-05 | -$150.00 10-K · filed 2021-03-05 | ||
| 2018-09-30 | -$150.00 10-Q · filed 2019-11-07 | |||
| 2017-12-31 | -$12.06K 10-K · filed 2020-03-06 | |||
| 2016-12-31 | $5.14K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07 | $12.32K derived: sum of 2 quarters · filed 2019-03-07 | $120.63K 10-K · filed 2019-03-07 | |
| 2016-09-30 | $7.17K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-06 | $115.49K 10-Q · filed 2017-11-06 | ||
| 2016-06-30 | $108.32K 10-Q · filed 2017-08-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |